F.D.A. advisers recommend that the agency authorize Moderna's vaccine for children 6 to 17.
Source: New York Times
An expert committee advising the Food and Drug Administration on Tuesday recommended Moderna’s coronavirus vaccine for use in children and adolescents ages 6 to 17, an important step before emergency authorization.
The F.D.A. will likely follow the panel’s advice in the coming days, as it has consistently during the pandemic, and grant authorization. But doing so may have little immediate impact, since the age group has had access to Pfizer-BioNTech shots since last year.
On Wednesday, the committee is scheduled to vote on a more pressing question: whether to recommend emergency authorization of both the Moderna and Pfizer-BioNTech vaccines for the nation’s youngest children, who still are not eligible for any coronavirus shots.
The vote on the Moderna vaccine came at the end of an all-day meeting that focused in part on the medical and social consequences of Covid-19 for about 50 million children and teens. After the F.D.A. issues its decision, the Centers for Disease Control and Prevention would take up the matter, perhaps as early as Friday.
Read more: https://www.nytimes.com/2022/06/14/us/politics/moderna-teens-vaccine-fda.html
Voting just completed.
Unanimous for Moderna for both questions - for ages "12 - 17" and for ages "6 - 11". They will discuss the infants/young children (6 months - 5 years) tomorrow.
= new reply since forum marked as read
